128940.KS
128940.KS
KR7128940004
HanmiPharm
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 1.547.531.098.760 1.495.501.575.560
3.5%
Cost of Revenue 663.124.174.430 678.464.579.520
2.3%
Gross Profit 884.406.924.330 817.036.996.040
8.2%
626.607.833.000 600.850.808.000
4.3%
Operating Income 257.799.091.330 216.186.188.040
19.2%
Pretax Income 213.477.735.470 171.253.974.790
24.7%
Net Income Common Stockholders 169.554.330.030 121.315.102.380
39.8%
-- --
--
-- --
--
ende